(Q51358473)

4 April 2018

title

Successful parallel development and integration of a plasmid-based biologic, container/closure system and electrokinetic delivery device. (English)

1 reference

4 April 2018

author name string

Henry Hebel

1

1 reference

4 April 2018

Heather Attra

2

1 reference

4 April 2018

Amir Khan

3

1 reference

4 April 2018

Ruxandra Draghia-Akli

4

1 reference

4 April 2018

language of work or name

English

0 references

publication date

24 August 2005

1 reference

4 April 2018

number of pages

8

1 reference

based on heuristic

inferred from page(s)

published in

Vaccine

1 reference

4 April 2018

volume

24

1 reference

4 April 2018

issue

21

1 reference

4 April 2018

page(s)

4607-4614

1 reference

4 April 2018

Priming of piglets against enterotoxigenic E. coli F4 fimbriae by immunisation with FAEG DNA.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.08.049

Use of a Sindbis virus DNA-based expression vector for induction of protective immunity against pseudorabies virus in pigs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.08.049

Modulation of immune responses to bovine herpesvirus-1 in cattle by immunization with a DNA vaccine encoding glycoprotein D as a fusion protein with bovine CD154.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.08.049

Optimization of DNA vaccination immune responses in dairy cows: effect of injection site and the targeting efficacy of antigen-bCTLA-4 complex

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.08.049

Perspectives on plasmid-based gene therapy: challenges for the product and the process

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.08.049

Issues for improving multiplasmid DNA vaccines for HIV-1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.08.049

Improvement of DNA vaccine immunogenicity by a dual antigen expression system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.08.049

Accelerated immune response to DNA vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.08.049

Improvement of nonviral gene therapy by Epstein-Barr virus (EBV)-based plasmid vectors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.08.049

Electroporation for gene transfer to skeletal muscles: current status

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.08.049

Impact of intrinsic DNA structure on processing of plasmids for gene therapy and DNA vaccines.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.08.049

Integrated process for purification of plasmid DNA using aqueous two-phase systems combined with membrane filtration and lid bead chromatography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.08.049

A rapid alkaline extraction procedure for screening recombinant plasmid DNA

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.08.049

Purification of pharmaceutical-grade plasmid DNA by anion-exchange chromatography in an RNase-free process.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.08.049

7 January 2021

Plasmid DNA purification

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.08.049

Production of plasmid DNA for human gene therapy using modified alkaline cell lysis and expanded bed anion exchange chromatography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.08.049

Evaluation of an ion‐exchange membrane for the purification of plasmid DNA

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.08.049

Large-scale capture and partial purification of plasmid DNA using anion-exchange membrane capsules

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.08.049

Self-administration with UniJect of the once-a-month injectable contraceptive Cyclofem

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.08.049

Oxytocin in prefilled Uniject injection devices for managing third-stage labor in Indonesia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.08.049

At-birth immunisation against hepatitis B using a novel pre-filled immunisation device stored outside the cold chain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.08.049

A prefilled injection device for outreach tetanus immunization by Bolivian traditional birth attendants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.08.049

Factors influencing the efficacy, longevity, and safety of electroporation-assisted plasmid-based gene transfer into mouse muscles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.08.049

Increased gene expression and inflammatory cell infiltration caused by electroporation are both important for improving the efficacy of DNA vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.08.049

Electroporation: theory and methods, perspectives for drug delivery, gene therapy and research

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.08.049

Theoretical analysis of localized heating in human skin subjected to high voltage pulses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.08.049

Kinetics of the temperature rise within human stratum corneum during electroporation and pulsed high-voltage iontophoresis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.08.049

10.1016/J.VACCINE.2005.08.049

7 January 2021

Identifiers

DOI

1 reference

4 April 2018

1 reference

4 April 2018